Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome

Roger Colobran, Elena Álvarez de la Campa, Pere Soler-Palacín, Andrea Martín-Nalda, Ricardo Pujol-Borrell, Xavier de la Cruz, Mónica Martínez-Gallo

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


© 2015 Elsevier Inc. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a monogenic autoimmune disease characterized by early-onset life-threatening multisystemic autoimmunity. This rare hereditary disorder is caused by loss-of-function mutations in the gene encoding the forkhead box P3 (FOXP3) transcription factor, which plays a key role in the differentiation and function of CD4+CD25+ natural regulatory T cells (Tregs), essential for the establishment and maintenance of natural tolerance. We identified a novel mutation in the FOXP3 gene affecting the Phe367 residue of the protein (F367V) in a family with three male siblings affected by IPEX. Two other mutations affecting the FOXP3 Phe367 residue (F367L and F367C) have been described previously. This unique situation of three mutations affecting the same residue in FOXP3 led us to study the molecular impact of these mutations on the structure of FOXP3 protein. Structure analysis showed that Phe367 is involved in a rich interaction network related to both monomer and dimer structure stabilization, and is crucial for FOXP3 regulatory activity. The relevance of this location is confirmed by the results of SIFT and PolyPhen-2 pathogenicity predictions for F367V mutation. In summary, as assessment of the pathogenicity of a novel mutation is crucial to achieve a proper molecular diagnosis, we analysed the impact of mutations affecting the Phe367 residue using a combined approach that provides a mechanistic view of their pathogenic effect.
Original languageEnglish
Pages (from-to)60-65
JournalClinical Immunology
Publication statusPublished - 1 Feb 2016


  • Autoimmunity
  • FOXP3
  • IPEX
  • Mutation
  • Primary immunodeficiency


Dive into the research topics of 'Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome'. Together they form a unique fingerprint.

Cite this